What it is
Endorphins are opioid peptides the body makes for itself. The name joins "endogenous" and "morphine". The one most studied is beta-endorphin, a chain of 31 amino acids. It was isolated from human pituitary glands and characterised for its morphine-like activity in 1976 (Li, Chung and Doneen, PMID 999687).
Beta-endorphin is not made on its own. The body builds a long precursor, pro-opiomelanocortin (POMC), and cuts it into several hormones. UniProt's record for human POMC (P01189, read 2026-11-17) places them along the chain:
| Piece of POMC | Positions | Length | Sequence (where short) |
|---|---|---|---|
| ACTH (corticotropin) | 138–176 | 39 | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
| Alpha-MSH | 138–150 | 13 | SYSMEHFRWGKPV |
| Beta-MSH | 217–234 | 18 | DEGPYRMEHFRWGSPPKD |
| Beta-endorphin | 237–267 | 31 | YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE |
| Met-enkephalin | 237–241 | 5 | YGGFM |
One detail the table makes plain: beta-endorphin starts with YGGFM, which is the whole of Met-enkephalin. The two sit at the same position of POMC in UniProt's record. The other opioid peptide families — the enkephalins and the dynorphins — are made from their own precursors, and the shared "YGGF" opening is the part that fits the opioid receptor. The POMC entry covers the precursor itself: how one chain becomes ACTH, MSH and beta-endorphin.
PubChem gives beta-endorphin the formula C158H251N39O46S and a molecular weight of 3,465.0 (CID 16132316).
How endorphins act
Beta-endorphin binds the opioid receptors on nerve cells, chiefly the mu receptor, the same receptor morphine uses. Activating it reduces the passage of pain signals and feeds into the brain's reward circuits. The drugs that block these receptors, naloxone and naltrexone, are how most human studies test whether an effect runs through endorphins: block the receptor and see whether the effect disappears.
ACTH comes from the same precursor and is released from the pituitary in response to stress, which is why stress studies often measure both.
What has been measured in people
The measurement problem comes first. Most human studies measure beta-endorphin in blood. A blood level does not show what is happening at receptors in the brain — which is why the best-known runner's high study scanned brains instead (our reading of why that design was chosen; the authors describe the brain effects as "barely investigated").
| Study | People | What was done | What was found |
|---|---|---|---|
| Boecker 2008, Cereb Cortex (PMID 18296435) | 10 athletes | PET scan with an opioid tracer, at rest and after 2 h of running (21.5 km on average) | Less tracer binding — read as more endogenous opioid activity — in prefrontal and limbic areas; euphoria rose and tracked the change |
| Fuss 2015, PNAS (PMID 26438875) | Mice | Running mice | As Fuss and colleagues summarise it in 2021: core features of a runner's high depended on cannabinoid receptors, not opioid receptors |
| Siebers 2021, Psychoneuroendocrinology (PMID 33582575) | 63 adults | 45 min treadmill running vs walking, double-blind naltrexone vs placebo | Euphoria and lower anxiety after running appeared with opioids blocked; the share reporting a runner's high was comparable in both groups; endocannabinoids rose |
What this adds up to: running does change opioid activity in the brain, on the 2008 scans. But the one trial that blocked opioids in people found the high itself did not depend on them. The two findings are not in direct conflict: one shows opioids are released, the other that the euphoria survives without their receptors. The popular phrase "endorphin rush" is older than both studies; a 1983 JAMA item titled Runner's "high" and a 1983 review of endorphins in exercise are already in PubMed.
ClinicalTrials.gov returns 326 studies for "endorphin" (2026-11-17). In the first 25 it returned, endorphin is an outcome being measured — in acupuncture, labour-pain, massage, hypnobirthing and nerve-block studies — never a substance given to participants.
Where it stands
Endorphins are a part of normal physiology, not a product. There is no approved endorphin medicine, and nothing sold as an "endorphin" supplement contains beta-endorphin as a listed active. The opioid system they belong to is also the target of prescription painkillers, which is a separate subject for a doctor. Sources opened 2026-11-17: UniProt P01189 (POMC); PubChem CID 16132316; Li, Chung and Doneen 1976 (PMID 999687, record); Boecker et al. 2008 (PMID 18296435); Fuss et al. 2015 (PMID 26438875); Siebers et al. 2021 (PMID 33582575); PubMed E-utilities and ClinicalTrials.gov API v2 counts.
